7wire Ventures

7wire Ventures is a distinguished venture capital firm based in Chicago, with a dedicated focus on early and growth-stage companies in the digital health, healthcare IT, and mobile health sectors. Co-founded by healthcare industry veterans Glen Tullman and Lee Shapiro, the firm leverages their profound operational expertise and extensive networks to identify and cultivate disruptive innovations. Their core investment thesis, "Connected Consumer Health," centers on empowering individuals to proactively manage their well-being and engage more effectively with the healthcare system through technology. This strategic focus positions them as a key player in advancing solutions that aim to improve health outcomes and enhance efficiency within the evolving healthcare landscape.

The firm's investment strategy is characterized by a hands-on approach, extending beyond capital provision to include strategic guidance, operational support, and access to crucial industry relationships. 7wire Ventures typically seeks companies demonstrating strong product-market fit, scalable business models, and a clear pathway to driving consumer engagement in health. Their initial investments for early-stage companies generally range from $1 million to $10 million, though they have the capacity to deploy larger sums for more mature, growth-stage opportunities. This flexible investment approach enables them to support companies through various critical development phases, from initial product launch to significant market expansion.

7wire Ventures has consistently expanded its capital base, reflecting strong investor confidence in its specialized strategy and proven track record. For example, the firm successfully closed its Fund IV in 2023, securing $200 million in capital commitments. This substantial fund empowers them to continue backing innovative companies that are fundamentally transforming healthcare delivery and consumer engagement. Their portfolio includes several successful ventures, some of which have achieved significant exits, underscoring their ability to identify and scale impactful healthcare technology solutions. The firm's commitment extends beyond mere financial investment, actively partnering with founders to navigate market complexities and accelerate growth.